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Envelope proteinsPorcine reproductive and respiratory syndrome virus (PRRSV) is classiﬁed into two genotypes, type 1 and
type 2, which share only about 60% genetic identity. Here, we report viable chimeric viruses in which the
envelope protein genes from ORF2a to ORF5 of vSHE (type 1) were swapped into the genetic backbone of
vAPRRS (type 2). We found that the envelope proteins of genotype 1 were fully functional in genotype 2
PRRSV, and the rescued chimeric progeny viruses showed robust genetic stability and similar replication
properties to the parental strains in vitro. To our knowledge, this is the ﬁrst study to report the substitution of
complete ORFs between different genotypes of porcine arterivirus. These ﬁndings pave the way to further
elucidate the structure–function relationship of PRRSV envelope proteins, andmay enable the development of
novel marker vaccines that can be used to differentiate vaccinated from infected animals.).
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV)
causes severe economic losses to the swine industry worldwide.
PRRSV belongs to the family Arteriviridae, order Nidovirales (Cavanagh,
1997; Snijder and Meulenberg, 1998), which includes the other
viruses, equine arteritis virus (EAV), lactate dehydrogenase-elevating
virus (LDV) and simian hemorrhagic fever virus (SHFV). PRRSV is
classiﬁed into two genotypes, the European genotype (type 1) and the
North American genotype (type 2) (Nelsen et al., 1999; Snijder and
Meulenberg, 1998). Interestingly, these two genotypes ﬁrst appeared
in the two different continents virtually simultaneously and cause
almost identical clinical manifestations, despite sharing only about
60% genetic identity at the nucleotide level over the entire genome
(Hanada et al., 2005; Nelsen et al., 1999). Such a paradox raises
question if structurally diversiﬁed PRRSV components play the same
function, based on which further functional domains can be
deciphered.
PRRSV is an enveloped virus containing a single positive-strand
RNA genome (Conzelmann et al., 1993). The genome comprises a 5′
terminal untranslated region (5′-UTR), nonstructural protein regions
(ORF1a and ORF1b), structural protein regions (ORF2a–ORF7), and a
3′ terminal untranslated region (3′-UTR), followed by a poly(A) tail
(Meulenberg, 2000; Meulenberg et al., 1995; Snijder andMeulenberg,
1998;Wu et al., 2001). PRRSV gene expression adopts a discontinuoustranscription strategy to synthesize a set of nested subgenomic
mRNAs (sg mRNAs) which possess the same 5′-UTR and 3′-UTRs with
the genomic RNAs (Pasternak et al., 2006). During the sg mRNAs
synthesis, the transcription-regulating sequence (TRS) is believed
to play a key role in mediating the discontinuous jumping of the
nascent “body” RNA to the leader (Pasternak et al., 2001). The leader
TRS (TRS-L), a hexa-nucleotide (UUAACC), is conserved while the
“body” TRSs (TRS-Bs) are diversiﬁed among different genotypes of
PRRSV (Meng et al., 1996;Meulenberg et al., 1993; Nelsen et al., 1999).
PRRSV not only synthesizes sg mRNAs that code for the structural
proteins using canonical TRS, but it also generates subgenomic RNAs
(sg RNAs) by noncanonical TRS (Meng et al., 1996; Yuan et al., 2000;
Zheng et al., 2010). This poses question regarding which factors
determine a functional TRS for PRRSV transcription.
ORF1 encodes at least 13 proteins, mainly involved in viral genome
replication and transcription (Kroese et al., 2008; Meulenberg, 2000).
Of the seven structural proteins, GP2a (encoded by ORF2a), GP3
(ORF3) and GP4 (ORF4) are thought to interact with each other to
form multimeric complexes, and along with E (ORF2b), they are
embedded in the virion envelope and are dubbed as minor envelope
proteins (Wieringa et al., 2003; Wissink et al., 2005). The four minor
envelope proteins are presumed to be involved in the process of virus
entry into target cells because loss-of-function of any of these proteins
affects viral infectivity, and it has been found that GP2a and GP4
interact with the cell receptor CD163 (Das et al., 2010; Wissink et al.,
2005). The non-glycoprotein E has been reported to possess ion
channel-like properties (Lee and Yoo, 2006). The major envelope
glycoprotein GP5 (ORF5) forms a disulﬁde-linked heterodimer with
the membrane protein M (ORF6), which is critical for arterivirus
2 Rapid Communicationparticle assembly (Faaberg et al., 1995; Snijder et al., 2003; Wissink
et al., 2005).
Little is known about the structure–function relationship of PRRSV
structural proteins. In this study, we investigated whether the
envelope proteins of the type 1 PRRSV could function in the backbone
of the type 2. We constructed a panel of chimeric full-length PRRSV
cDNA clones in which the genes encoding the type 2 envelope
proteins (ORF2a to ORF5) were replaced by the equivalent genes from
the type 1 virus. Viable chimeric progeny viruses were rescued and
analysed, based which further functional dissection of these PRRSV
structural proteins can be conducted.
Results
Transfer of the type 1 envelope protein genes into a type 2 genetic
background
Limited homology is observed between the envelope proteins
(GP2a to GP5) of the type 1 and type 2 PRRSV strains (Table 1). The
ORFs differ in length, nucleotide identity ranging from 61 to 72%,
while the maximum amino acid sequence identity is 76%. To dissect
the structure–function relationship of the envelope proteins, we
investigated whether the envelope proteins could be functional in the
genetic background of a different PRRSV genotype. Utilizing two full-
length infectious cDNA clones pAPRRS (derived from type 2 strain)
and pSHE (derived from type 1 strain), we constructed a panel of
chimeric clones (Fig. 1). For swapping heterologous genes conve-
niently, an AscI restriction enzymatic recognition site was inserted
between ORF1b and ORF2a of pAPRRS to generate pAPRRSasc. Such
genetic manipulation did not signiﬁcantly impair virus replication (Yu
et al., 2009). Based on pAPRRSasc, the envelope protein genes
(ORF2a–ORF5) were replaced with their counterparts from pSHE.
Because the coding regions for theminor envelope proteins share long
overlapping sequences between adjacent ORFs, we generated chime-
ric plasmids pAPRRS-SHE234, which contained the entire genomic
region from ORF2a to ORF4 of vSHE. To further investigate if the virus
viability was affected by the potential interaction between the GP5, M
and minor envelope proteins, we also constructed chimeric plasmids
pAPRRS-SHE5 and pAPRRS-SHE2345, in which the ORF5 or all of
the envelope protein genes, ORF2a–ORF5, were replaced with those
of vSHE. Nucleotide sequencing analysis veriﬁed the identity of the
plasmids.
Cytopathic effect (CPE), such as cells agglomeration and detach-
ment, was observed on days 4 to 6 post-transfection in MARC-145
cells which transfected with in vitro RNA transcripts derived from
pAPRRSasc, pAPRRS-SHE234, pAPRRS-SHE2345 and pAPRRS-SHE5,
respectively, but not in mock-transfected control. Indirect immuno-
ﬂuorescence assay (IFA) conﬁrmed that the observed CPE was PRRSV-
speciﬁc, as the transfected cells reacted positively when stained with
monoclonal antibodies (mAbs) speciﬁc for the nucleocapsid protein
(N) and nonstructural protein 2 (NSP2) of type 2 PRRSV (Fig. 2). To
further conﬁrm that the rescued viruses were originated from the
transfected RNA, the viral RNAwas extracted from the supernatants ofTable 1
Comparison of vSHE (GenBank accession# GQ461593) to vAPRRS (GQ330474) in
nucleotide (nt) and deduced amino acid (a.a.) level.
ORF nucleotide (bp) nt identity
(%)a
deduced a.a.
length
a.a. identity
(%)a
vSHE vAPRRS vSHE vAPRRS
ORF2a 750 771 67 249 256 63
ORF2b 213 222 72 70 73 76
ORF3 798 765 65 265 254 60
ORF4 552 537 67 183 178 72
ORF5 606 603 61 201 200 53
a The identity were aligned by the clustal W method in DNAStar software.passage 1 (P1) viruses for complete genome sequencing. Sequence
analysis conﬁrmed that the progeny viruses possessed chimeric
genomic structures, in which the target ORFs of vAPRRS had been
successfully replaced by their counterparts from vSHE (data not
shown). Several nonsynonymous point mutations were detected in
other genomic regions compared to parental virus vAPRRS, as
summarized in Supplementary Table S1. The rescued viruses were
designated vAPRRSasc, vAPRRS-SHE234, vAPRRS-SHE2345 and
vAPRRS-SHE5, respectively. We further assessed the genetic stability
of the chimeras in vitro. The chimeric viruses were passaged con-
secutively to passage 8 (P8) in freshMARC-145 cells using a 1000-fold
diluted inoculum. The P8 viral RNA was extracted, and the whole
structural protein encoding genes were analysed by RT-PCR and
sequencing. The results demonstrated that the heterologous ORFs
were stablymaintained in P8 viruses, and no amino acidmutationwas
detected compared to P1 chimeras (data not shown). This indicated
that the chimeric PRRSVs have robust genetic stability at least in vitro.
Next, we investigated the expression proﬁles of the swapped
heterologous genes in chimeric viruses. Virus-infected MARC-145
cells were stained with mAbs (kindly provided by Dr Hans Nauwyck
at Ghent University) against GP3 (VII2D/5-1D) and GP5 (VII2H/2-4D)
of type 1 PRRSV, and a customer-made peptide-speciﬁc antibody
against GP4 (ARV-SHE-GP4, Shanghai GL Biotech company) of vSHE.
As shown in Fig. 2, the type 1 speciﬁc proteins encoded by swapped
genes were detected in corresponding chimeras infected cells. As no
speciﬁc antibodies against the GP2a and E proteins were available, we
were unable to investigate the expression of these heterologous
proteins in vAPRRS-SHE234 and vAPRRS-SHE2345 infected cells.
However, we speculate that these two envelope proteins were also
expressed, as all of these proteins are believed to be crucial for viral
infectivity.
The virological characteristics and transcriptional proﬁles of the chimeras
To investigate the virological characteristics of chimeric viruses,
we performed viral plaque morphology and growth kinetics analysis
with passage 3 (P3) viruses. As shown in Fig. 3A, the plaque
morphology of the chimeric viruses, vAPRRS-SHE234 and
vAPRRSV2345, was similar to the plaques observed with vAPRRS.
However, vAPRRS-SHE5 exhibited much smaller plaques, although its
peak titer was virtually similar with that of other chimeras. The peak
titers of vAPRRS-SHE234, vAPRRS-SHE2345 and vAPRRS-SHE5 were
5.1×105, 1.0×105 and 2.0×105 plaque forming unit per ml (PFU/ml),
respectively, which were a little lower than that of the parental strains
vAPRRS (7.9×105 PFU/ml) and vSHE (6.3×105 PFU/ml). The ﬁnding
that chimeric viruses had a lower peak titer than thewild-type viruses
was not unexpected. However, there was no signiﬁcant difference in
the growth curve between chimeras and parental strains (Fig. 3B),
suggesting that the heterologous envelope protein genes did not
dramatically affect viral growth, and the envelope proteins of type 1
were fully functional in type 2 PRRSV.
Both type 1 and type 2 PRRSVs utilize the same TRS-L (UUAACC),
yet their TRS-Bs are diversiﬁed. To investigate how the transcription
process was affected in the chimeric viruses, sg RNAs were RT-PCR
ampliﬁed from the total cellular RNA, followed by cloning and
nucleotide sequence determination. The leader–body junction
sequences and their genomic positions of sg RNAs mediated by
canonical TRS-Bs were summarized in Table 2. The sg RNA2 from all of
the chimeras, sg RNA5 from vAPRRS-SHE5, the TRS-Bs and their
ﬂanking sequences were the same as the parental strain vAPRRS.
While sg RNAs transcribed from swapped genes and the genes
immediately downstream, the TRS-Bs and their ﬂanking sequences
were the same as the donor virus vSHE. In addition, some small sg
RNAs were detected from chimeras while not parental viruses, in
which the leader-body junction sites were situated downstream of
the initial codon of the corresponding ORFs (supplementary Table S2).
Fig. 1. Schematic organization of the parental and chimeric full-length cDNA clones. The genomic organization of the type 1 PRRSV, vSHE, is shown as a black box, while that of the
type 2 PRRSV, vAPRRS, is represented as an open box. pAPRRSasc was generated by inserting the AscI restriction enzyme recognition sequence (italics in small case, ggcgcgcc)
between ORF1b and ORF2a, using site-speciﬁc mutation PCR. Then, the envelope protein genes ORF2a–4 of pAPRRSasc were replaced with those of pSHE by splicing overlap
extension (SOE) PCR, generated pAPRRS-SHE234. pAPRRS-SHE2345 and pAPRRS-SHE5 were constructed in the same manner. The junction regions of each chimeric plasmid are
shown in the nucleotide sequences (the nucleotides of pAPRRS are shown in lowercase, while pSHE nucleotides are in uppercase).
3Rapid CommunicationThe roles of these small sg RNAs remained to be determined. Overall,
the chimeric viruses transcribed corresponding hybrid sg RNAs, which
shared the same 5′-UTR with vAPRRS, and the TRS-Bs from the donor
virus remained functional in the chimeric viruses. These results
indicated that TRS-Bs remained unchanged when they were swapped
together with their ﬂanking sequences, while some cryptic TRS-Bs
were provoked to form novel sg RNAs from swapped genes.
Discussion
As a relatively small RNA virus, PRRSV paradoxically encodes six
known envelope proteins (GP2, E, GP3, GP4, GP5 and M), all of which
are crucial for virus infectivity (Meulenberg et al., 1995; Nelsen et al.,
1999; Wu et al., 2001). The structure–function relationship of these
proteins remains largely undetermined. Despite causing similar
clinical symptoms, the two genotypes of PRRSV, type 1 and type 2,
are genetically diversiﬁed. Whether the genes and encoded proteins
from different genotypes play the same roles andwork in concert is an
interesting question.
Chimeric arteriviruses have previously been constructed to
investigate virus virulence determinants or cell tropism. Using two
infectious cDNA clones derived from two distinct virulent type 2
PRRSV strains, Wang and colleagues constructed chimeric viruses
with exchanged structural proteins, and showed that such chimeric
virus exhibited good immunogenicity and attenuated virulence,
suggesting that chimeric viruses could be promising vaccine candi-
dates (Wang et al., 2008). Another group also constructed similar
chimeric PRRSVs which contained different envelope-associated
structural proteins from different parental viruses (Kim and Yoon,
2008). All of these chimeric viruses were generated by exchanging
genes between various PRRSV strains belong to the same genotype,
which shared about 95% identity. Dobbe and coworkers engineered
viable chimeric EAVs, in which the ectodomain of GP5 was replaced
with that of PRRSV or LDV, and demonstrated that the ectodomain of
GP5 is not the main determinant of EAV cellular tropism (Dobbe et al.,
2001). Using the same approach, similar conclusion was also made for
the M protein (Verheije et al., 2002). In this study, we exchanged thecomplete envelope protein genes (ORF2a–ORF5) between two PRRSV
genotypes and generated viable inter-genotypic chimeric viruses. The
chimeras exhibited similar virological characteristics to their parental
viruses, indicating that the envelope proteins of type 1 virus were
fully functional in type 2 PRRSV. Unfortunately, the two genotype
strains of PRRSV shared the same cellular tropism in vitro. Further
development of inter-species chimeric viruses with different cell
tropism is therefore required to investigate the viral attachment
protein, an enigma so far for arterivirus.
Little is known about the functional domains of the PRRSV
envelope proteins. Amino acid sequences comparison indicate that
the envelope proteins between two genotypes does contain con-
served domains and putative N-linked glycosylation sites, despite low
sequences identity (Fig. 4). It has previously been reported that the
GP5 and M proteins are key components for arterivirus assembly, and
that the formation of the GP5-M heterodimer in type 1 PRRSV,
which is linked by a disulﬁde bond between cysteine (Cys) residues at
positions 50 and 8, respectively, is a prerequisite for virion assembly
(Faaberg et al., 1995; Snijder et al., 2003; Wissink et al., 2005). In both
vAPRRS-SHE2345 and vAPRRS-SHE5, the GP5 and M proteins
originate from different genotype PRRSVs. However, progeny viruses
were successfully rescued suggesting that the hybrid GP5-M hetero-
dimers, in which GP5 protein originated from vSHE and M protein
from vAPRRS, were still formed. According to the deduced amino acids
sequences, the conserved Cys residues were located at position 48 in
the GP5 and 9 in the M protein of vAPRRS, respectively (Fig. 4).
Overlapping sequences exist between ORF5 and ORF6 in vAPRRS and
vSHE. In vAPRRS-SHE2345 and vAPRRS-SHE5, the exact sequences of
ORF5 from vSHE were retained while the overlapping sequences of
vAPRRS ORF6 with ORF5 were changed to that of vSHE (as shown in
Fig. 1), such that the conserved Cys in the M protein remained at
position 8 in the chimeras. Accordingly, the Cys residue at position 50
of the GP5 likely interacts with the Cys at position 8 of the M in the
two chimeras, and such interaction would lead to the formation of a
hybrid heterodimers. Recently, Das et al. (2010) reported that the GP5
protein also strongly interacts with GP4. In the present study, vAPRRS-
SHE5 exhibited smaller plaque in MARC-145 cells (Fig. 3A). This may
Fig. 2. Indirect immunoﬂuorescence assay of infected or transfected MARC-145 cells. After 48 hours post-infection or transfection, the cell monolayer in six-well plates was ﬁxed in
cold methanol, then blocked with 1% BSA at room temperature. The cells were incubated with monoclonal antibodies against N and NSP2 proteins which are speciﬁc for type 2
PRRSV, or with antibodies against the GP3, GP4 (vSHE peptides-speciﬁc) or GP5 proteins of type 1 PRRSV at 37 °C for 2 hours. Finally, the cells were stained with anti-mouse Alexa-
568-labeled or anti-rabbit Alexa-555-labeled (for GP4) secondary antibodies. The immunoﬂuorescence was visualized using an inverted ﬂuorescence microscope.
4 Rapid Communicationresult from a somewhat impaired interaction between the GP4
(originated from vAPRRS) and GP5 (from vSHE). However, such
virological characteristics were not observed in vAPRRS-SHE234,
which also harbors a heterologous pair of GP4 (vSHE) and GP5
(vAPRRS). It could be possible that the GP4 of vSHE interacts well with
the GP5 of vAPRRS since GP4 is more inter-genotypic conserved
(Fig. 4). If this is the case, the exact residues or domains involved in
this process would be an interesting subject for future study. PRRSV
GP3 contains a hypervariable region at the C terminus, and a
truncated sequence in vAPRRS (Fig. 4). Nonetheless, functional
complementation of the GP3 protein in vAPRRS with that of vSHE
indicated that the C terminus could be functionally nonessential. This
ﬁnding was consistent with previous reports that an increasing
number of GP3 deletion mutants are being isolated in the ﬁeld
(Oleksiewicz et al., 2000; Ropp et al., 2004).
Like other arterivirus, PRRSV adopts a sophisticated system of sg
mRNA synthesis, but the detailed mechanism is still poorly under-
stood (Pasternak et al., 2006). In the present study, inter-genotypic
hybrid sg RNAs was detected, which consisted of the 5′-UTR from
vAPRRS and the swapped ORFs from vSHE. The fact that the canonical
TRS-Bs in vSHE were still functional indicated that TRS-Bs from both
genotypes of PRRSV share common features. In particular, the ﬂanking
sequences are probably essential for TRS-Bs function. In addition, wealso detected a series of small sg RNAs from chimeras, in which the
leader-body junction sites werewithin the corresponding ORFs. These
so-called noncanonical TRS-B-mediated sg RNAs have also been
reported by others (Meulenberg et al., 1993; Zheng et al., 2010). We
speculate that the activation of noncanonical TRS-Bs was caused by
the attenuation of canonical TRS-Bs.
As a RNA virus, PRRSV exhibits a high mutation rate, and genetic
recombination has been reported in both genotypes (Li et al., 2009; van
Vugt et al., 2001; Yuan et al., 1999). The co-existence of both genotype
strains in some countries creates the opportunity for inter-genotypic
recombination, although this has not been detected in the ﬁeld to date
(Dewey et al., 2000). The viable inter-genotypic chimeras described
here suggest that RNA recombination between different genotypes of
PRRSVcouldbepossible. The twogenotypesof PRRSVareoriginatedand
prevalent in different continents, but this geographical separation has
been compromisedby the international swine trade andwidespreaduse
of a type 2 vaccine, IngelvacMLV, in Europe for a period of years (Dewey
et al., 2000; Ropp et al., 2004). The concern is that if inter-genotypic
recombinants were generated in the ﬁeld, current vaccines and
diagnostic techniques may become invalid.
In conclusion,we found that the envelopeprotein genes (ORF2a–5) of
type 2 PRRSV could be replaced by these of type 1, and the heterologous
envelope proteins were fully functional for virus replication although
Fig. 3. The virological characteristics of the chimeric viruses. (A) Plaque morphology. MARC-145 cells in six-well plate were infected with chimeric or parental viruses as detailed in
Materials and methods, and then overlaid with EMEM medium containing 2% FBS and 1% low melting agarose. After four days, the cell monolayers were stained with crystal violet.
(B) Viral growth kinetics in MARC-145 cells. Cells in six-well plates were infected with chimeric and parental strains at an MOI of 0.01 PFU/ml. An aliquot of 0.2 ml of culture
supernatant was collected and replenished with the same volume of fresh medium at the indicated time points. The virus titers of the collected supernatants were determined by
plaque assay and expressed as PFU/ml (□, vAPRRS; △, vSHE; ○, vAPRRSasc; ■, vAPRRS-SHE234; ▲, vAPRRS-SHE2345; ●, vAPRRS-SHE5).
5Rapid Communicationvery low homology existed between the two genotype PRRSVs. The
chimeric viruses generated here paved the way for further structure–
function relationship analysis, anddevelopmentof novelmarker vaccines
that can be used to differentiate vaccinated from infected animals.
Materials and methods
Cells, viruses and antibodies
TheMARC-145 cell line (ATCC, Manassas, VA, USA) was cultured in
Eagle's minimal essential medium (EMEM) with 10% fetal bovine
serum (FBS, Gibco-BRL, Gaithersburg, MD, USA) and maintained inTable 2
The leader-body junction sequences of sg RNAs mediated by canonical TRS-Bs in chimeras,
strains.
sg RNA Chimeras Leader-body jun
Leader
2 vAPRRS-SHE234, APRRS-SHE2345, vAPRRS-SHE5 genomic
subgenomic
3 vAPRRS-SHE234, vAPRRS-SHE2345 genomic
subgenomic
vAPRRS-SHE5 genomic
subgenomic
4 vAPRRS-SHE234, vAPRRS-SHE2345 genomic
subgenomic
vAPRRS-SHE5 genomic
subgenomic
5 vAPRRS-SHE234, vAPRRS-SHE2345 genomic
subgenomic
vAPRRS-SHE5 genomic
subgenomic
6 vAPRRS-SHE2345, vAPRRS-SHE5 genomic
subgenomic
vAPRRS-SHE234 genomic
subgenomic
7 vAPRRS-SHE234, vAPRRS-SHE2345, vAPRRS-SHE5 genomic
subgenomic
genomic
subgenomic
a The letters underlined indicate the TRS-L in 5′-UTR, TRS-Bs in genome and leader-body
b Distance (in nucleotides) between the leader-body junction motif and the initiation AU
c The isolated clone number containing the indicated TRS-B.EMEM with 2% FBS at 37 °C with 5% CO2. The type 2 PRRSV strain,
vAPRRS, was derived from the infectious clone pAPRRS (GenBank
accession: GQ330474; Yuan and Wei, 2008). The type 1 PRRSV strain,
vSHE, was rescued from the infectious clone pSHE (GQ461593; Yuan
et al., unpublished data), based on the attenuated vaccine strain
AMERVAC-PRRS/A3 (Hipra Laboratory). The vSHE shares 95% identity
with LV strain (phenotype strain of type 1 PRRSV) in genome level.
Monoclonal antibodies (mAbs) speciﬁc for N protein (N-McAb) and
nonstructural protein 2 (Nsp2-McAb) of type 2 PRRSV were kindly
provided by Dr. Ying Fang (South Dakota State University, USA). mAbs
against GP3 (VII2D/5-1D) and GP5 (VII2H/2-4D) of type 1 PRRSVwere
provided by Dr. Hans J. Nauwynck (Ghent University, Belgium). Rabbitand comparison of the leader-body junction positions between chimeras and parental
ction sequences of chimerasa Leader-body junction positionb
CCACCCCUUUAACCAUGUCUGG Chimeras vAPRRS vSHE
CCUGUCAUUGAACCAACUUUAG 19 (7c) 19 (6) 38 (5)
CCACCCCUUGAACCAACUUUAG
GGCCCAAGUUGACCGAUUUCAG 11 (5) 83 (4) 11 (6)
CCACCCCUUUGACCGAUUUCAG
GGGUCAAAUGUAACCAUAGUAUA 83 (4)
CCACCCCUUUAACCAUAGUAUA
GACAAAAUUCAACCAUAUCUAC 83 (5) 4 (6) 83 (7)
CCACCCCUUCAACCAUAUCUAC
CAAUUGGUUUCACCUAGAAUGG 4 (4)
CCACCCCUUUCACCUAGAAUGG
GUGGGCUACAACCAUUGCUUGU 32 (6) 40 (5) 32 (5)
CACCCCUUUAACCAUUGCUUGU
CAACUGUUUUACCCUGUCUUUU 40 (5)
CCACCCCUUUACCCUGUCUUUU
UUAAAGCUCAACCCUUGACGAG 24 (7) 17 (5) 24 (6)
CCACCCCUCAACCCUUGACGAG
CAACCCCUUUAACCAGAGUUUC 17 (4)
CCACCCCUUUAACCAGAGUUUC
GGCAAAUGAUAACCACGCAUU 123 (4) 123 (5) 9 (5)
CCACCCCUUUAACCACGCAUU
GGAGUGGUUAACCUUGUUAAA 9 (3) 9 (3)
CCACCCCUUUAACCUUGUUAAA
junction motif in every sg RNA.
G of individual sg RNA.
Fig. 4. Alignment of the deduced amino acid sequences of the GP2a, E, GP3, GP4 and GP5 proteins of vAPRRS and vSHE, using the ClustalWmethod within the DNAStar software. The
dots in the SHE sequences represent amino acids that are identical with the APRRS, solid boxes show the putative N-linked glycosylation sites, the arrow in GP5 indicates the
conserved cysteine residues at position 48 in the APRRS and position 50 in the SHE, and the dotted line boxes indicate the hypervariable region in GP3.
6 Rapid Communicationpeptide-speciﬁc antibody directed against GP4 of vSHE (ARV-SHE-
GP4, recognizes the peptide: PHGVSTAQENIPFGKPSQC) was obtained
from GL Biochem (Shanghai, China). The secondary antibodies Alexa
ﬂuor 568-labeled goat anti-mouse IgG and Alexa ﬂuor 555-labeled
goat anti-rabbit IgG were purchased from Molecular Probes (Invitro-
gen, Carlsbad, CA, USA).Construction of chimeric full-length cDNA clones
Site-speciﬁc mutation PCR was conducted to introduce an AscI
restriction enzyme recognition site immediately upstream of the
ORF2 start codon in the infectious cDNA clone, pAPRRS, as previously
described (Yu et al., 2009). This construct was designated pAPRRSasc
(Fig. 1). To construct the chimeric full-length cDNA clones, the hybrid
DNA fragments which consisted of target ORFs from pSHE and
nucleotide sequences from pAPRRS were ampliﬁed through splicing
overlap extension (SOE) PCR, according to a previous report (Warrens
et al., 1997). Brieﬂy, using the construction of pAPRRS-SHE234 as an
example, fragment SHE234 (ORF2a–ORF4 of vSHE) was ampliﬁed
from pSHE using the primer pair FS234asc and RS4-A5, and fragment
APRRS56 (ORF5–ORF6 of vAPRRS) was ampliﬁed from pAPRRS using
the primer pair FS4-A5 and RA14780. Then using SHE234 and
APRRS56 as templates, the hybrid fragment SHE234–APRRS56 were
ampliﬁed via SOE PCR using the primer pair FS234asc and RA14780.
All of the oligonucleotide primer sequences were listed in Table 3. Thegenerated hybrid fragment was cloned into the pCR-blunt II-TOPO
vector (Invitrogen) following the manufacturer's recommendations
to construct an intermediate plasmid. Then, the hybrid fragment was
subcloned into pAPRRSasc, via enzyme digestion with AscI and XbaI
(New England Biolabs, Ipswitch, MA, USA), to yield the chimeric full-
length cDNA clone pAPRRS-SHE234. The other chimeric plasmids,
pAPRRS-SHE2345 and pAPRRS-SHE5, were generated in the same
manner (Fig. 1). In this two constructs, the ﬁrst 16 nucleotide acids of
APRRS ORF6 were changed into the last 13 nucleotide acids of SHE
ORF5, because overlapping sequences exist between ORF5 and ORF6
in both PRRSVs. All the constructs were veriﬁed by sequencing.Rescue of the chimeric viruses
The full-length chimeric plasmids were isolated using the QIAprep
Spin Miniprep kit (Qiagen, Hilden, Germany), according to the
manufacturer's protocol, followed by restriction enzyme mapping
and nucleotide sequence veriﬁcation. The plasmids were linearized
with XhoI (New England Biolabs), that cuts immediately downstream
of the poly(A) tail, and puriﬁed with a QIAquick PCR puriﬁcation kit
(Qiagen). Then, 1 μg of the puriﬁed DNA template was used for in vitro
RNA transcription, using a T7 mMessage Machine Kit (Ambion INC,
Austin, TX, USA), according to the manufacturer's recommendations.
The RNA integrity was veriﬁed using native RNA agarose gel (1%)
electrophoresis, and the RNA was quantiﬁed using a spectrometer at
Table 3
Primers used for this article.
Primera Sequence (5′–3′)b Application
FA12asc GAGGCGCGCCAATGAAATGGGGTCCATGC PCR to insert Asc I between ORF1 and ORF2 of pAPRRS.
RA12asc TTGGCGCGCCTCAATTCAGGCCTAAAGTTG
FS234asc GAAGGCGCGCCATGCAATGGGGTTACTGTGGAG SOE PCR to replace the ORF2–4 of pAPRRS with the counterparty of pSHE
RS4-A5 TCCCCAACATACTTAAACATTCATATCGCCAAGAGAATGG
FS4-A5 CCATTCTCTTGGCGATATGAATGTTTAAGTATGTTGGGGA
RA14780 GCATCTAGAGGTGATGAACCTCCAAGTTTCTATGG
FS234asc GAAGGCGCGCCATGCAATGGGGTTACTGTGGAG SOE PCR to replace the ORF2–5 of pAPRRS with the counterparty of pSHE
RS5-A6 GCTGTCATGACAAAAGTCGTCTAGGCTTCCCATTGCTCAG
FS5-A6 CTGAGCAATGGGAAGCCTAGACGACTTTTGTCATGACAGC
RA14780 GCATCTAGAGGTGATGAACCTCCAAGTTTCTATGG
FA234asc GAGGCGCGCCAATGAAATGGGGTCCATGC SOE PCR to replace the ORF5 of pAPRRS with the counterparty of pSHE.
RA4-S5 CAATTTGTGAGAACATCTCATACTTAAACATTCAAACTGCC
FA4-S5 GGCAGTTTGAATGTTTAAGTATGAGATGTTCTCACAAATTG
RS5-A6 GCTGTCATGACAAAAGTCGTCTAGGCTTCCCATTGCTCAG
FS5-A6 CTGAGCAATGGGAAGCCTAGACGACTTTTGTCATGACAGC
RA14780 GCATCTAGAGGTGATGAACCTCCAAGTTTCTATGG
FA6 GTATAGGTGTTGGCTCTATGCCTTG RT-PCR ampliﬁcation for the sg RNA2–7 of APRRS sequence.
RA12661 TTTACAGGTCTCGGCTTC
RA13077 CCCTAGCTCGTCGTGATCGT
RA13804 CGCACATGATCGACCAC
RA14234 GCGTAGATGCTACTCAGGACATACC
RA14880 ATGCGTGGTTATCATTTGCCGTAATC
RA15306 CTCCACAGTGTAACTTATCCTCC
FS9 TAGGGTATTCCCCCTACATTCACGACAC RT-PCR ampliﬁcation for the sg RNA2–7 of SHE sequence.
RS12545 TTAGCTCGAATGATGTGTTGCCGTG
RS13200 TATCGTAATGTACTGGGGAATACCG
RS13497 TCATATCGCCAAGAGAATGGCGAAC
RS14096 GGCTTCCCATTGCTCAGCCGAAGTC
RS14605 CCGGCCATACTTGACGAGGTTAACC
RS14977 GCACCCTGACTGGCGGATGTAGAAG
a Primer names are organized in groups. Preﬁxes: F, forward PCR primer; R, reverse PCR primer; A, sequence from pAPRRS (GenBank accession number GQ330474); S, sequence
from pSHE (GenBank accession number GQ461593).
b Restriction sites introduced by PCR are underlined.
7Rapid CommunicationOD260. MARC-145 cells were inoculated into a six-well plate at
approximately 60–80% conﬂuency. The cells were then transfected
with 1 μg of RNA per well using the DMRIE-C reagent (Invitrogen), as
recommended by the manufacturer, followed by incubation at 37 °C
with 5% CO2. The transfected cells were monitored daily and
cytopathic effect (CPE) was recorded. When about 80% CPE was
observed, the supernatants of the cell cultures were harvested and
designated as passage 0 (P0). Then, 1000-fold diluted P0 viruses were
passaged consecutively up to passage 8 (P8) in fresh MARC-145 cells.
All of the rescued viruses were aliquoted and stored at −70 °C.RT-PCR and nucleotide sequencing
Viral genomic RNA was isolated from the supernatant of the
cultured cells using a QIAprep Viral RNA Mini Kit (Qiagen), as
instructed by the manufacturer. To verify the chimeric genomic RNA
in the rescued viruses, RT-PCR was performed using avian myelo-
blastosos virus reverse transcriptase (TaKaRa) and pfuUltra II Fusion
HS DNA polymerase (Stratagene, USA). The complete genomes were
ampliﬁed in 7 segments, followed by nucleotide sequence determi-
nation as previously described (Lv et al., 2008).
Total intracellular RNA was isolated using Trizol Reagent (Invitro-
gen), according to the manufacturer's instructions. The sg RNAs were
ampliﬁed by RT-PCR with speciﬁc primer pairs. The forward primers
FA6 and FS9 were designed to bind the upstream of 5′-UTR of vAPRRS
and vSHE, respectively. The reverse primers located in the individual
ORFs of the structural proteins (ORF2–ORF7), such that the speciﬁc
leader-body junctions of the sg RNAs could be determined (Table 3).
The RT-PCR products were cloned into the pGEM-T vector (Promega,
Madison, USA) and subjected to nucleotide sequencing.Indirect immunoﬂuorescence analysis
The indirect immunoﬂuorescence assay (IFA) was performed as
described previously, with minor modiﬁcations (Yu et al., 2009).
Brieﬂy, After 48 hours post-inoculation at a low multiplicity of
infection (MOI, 0.01), or transfection with RNA transcripts, the MARC-
145 cells in six-well plates were ﬁxed in cold methanol, then blocked
in 1% BSA at room temperature. The ﬁxed cells were incubated with
speciﬁc antibodies against the corresponding target proteins at 37 °C
for 2 hours. After extensive washing with phosphate-buffered saline
(PBS), the cells were incubated with anti-mouse Alexa-568-labeled or
anti-rabbit Alexa-555-labeled secondary antibodies for 1 hour. Finally,
the ﬂuorescence was visualized under an Olympus inverted ﬂuores-
cence microscope ﬁtted with a camera.
Viral plaque and growth kinetics assay
To examine the plaque morphology of the chimeric viruses, ten-
fold serially diluted virus suspensions were incubatedwithMARC-145
cells in six-well plates. After a 1-hour adsorption, the cell monolayers
were washed off and then overlaid with a mixture of EMEM medium
containing 2% FBS and 1% low melting agarose (Cam-brex, Rockland,
ME, USA). When the agarose overlay solidiﬁed, the plate was inverted
(bottom up) in a humidiﬁed CO2 incubator at 37 °C for four days. The
resulting plaques were stained with crystal violet (5% w/v−1 in 20%
ethanol).
Multiple-step growth curve analysis was conducted as previously
described (Yu et al., 2009). Brieﬂy, MARC-145 cells were infected with
the chimeric and parental strains at low MOI (0.01). After a 1-hour
adsorption, the cells were washed off with PBS twice and cultured
with EMEM (2%FBS). At the indicated time points (12, 24, 36, 48, 60,
8 Rapid Communication72, 84, 96 and 108 hours) post-infection, aliquots of the culture
supernatants (0.2 ml/well) were collected, and same volume of fresh
medium was replenished. Viral titration was performed by plaque
assay. Based on viral titers, the growth curves were determined.
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